COMPLICATIONS OF BONE MARROW TRANSPLANT side effect
What is COMPLICATIONS OF BONE MARROW TRANSPLANT ?Drugs associated with COMPLICATIONS OF BONE MARROW TRANSPLANT
ALDURAZYME AMMONUL DEFERASIROX FLUDARA FLUDARABINE FORTEO IMATINIB PROGRAF RITUXAN VELCADECOMPLICATIONS OF BONE MARROW TRANSPLANT : Prograf Side Effects Report #5679942-5
Physician from JAPAN reported PROGRAF problem on Mar 07, 2008. Male patient, 65 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, cytomegalovirus antigen positive, pulmonary alveolar haemorrhage, . PROGRAF dosage: unknown. Patient recovered.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Forteo Side Effects Report #5634397-1
FORTEO problem was reported by a Consumer or non-health professional from CANADA on Feb 13, 2008. Female patient, 60 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, pneumonia, . FORTEO dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, LOSEC I, DOMPERIDONE, SEPTRA, CALCIUM, VITAMIN D. Patient was hospitalized. Patient recovered.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Fludara Side Effects Report #5635026-3
Consumer or non-health professional from GERMANY reported FLUDARA problem on Feb 07, 2008. Female patient was diagnosed with immunosuppression and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . FLUDARA dosage: TOTAL DAILY DOSE: 30 MG/M2. During the same period patient was treated with AMSACRINE, CYTARABINE, BUSULFAN, CYCLOPHOSPHAMIDE, ANTITHYMOCYTE GLOBULIN, ANTITHYMOCYTE GLOBULIN, IMMUNOSUPPRESSANTS. Patient died.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Fludara Side Effects Report #5635029-9
FLUDARA problem was reported by a Consumer or non-health professional from GERMANY on Feb 07, 2008. Female patient was diagnosed with immunosuppression and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . FLUDARA dosage: TOTAL DAILY DOSE: 30 MG/M2. During the same period patient was treated with AMSACRINE, CYTARABINE, BUSULFAN, CYCLOPHOSPHAMIDE, ANTITHYMOCYTE GLOBULIN, ANTITHYMOCYTE GLOBULIN, IMMUNOSUPPRESSANTS. Patient died.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Fludarabine Side Effects Report #5635030-5
Consumer or non-health professional from FRANCE reported FLUDARABINE problem on Feb 07, 2008. Female patient was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . FLUDARABINE dosage: TOTAL DAILY DOSE: 30 MG/M2. During the same period patient was treated with TREOSULFAN, ANTITHYMOCYTE GLOBULIN. Patient died.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Fludara Side Effects Report #5639537-6
FLUDARA problem was reported by a Consumer or non-health professional from GERMANY on Feb 07, 2008. Female patient was diagnosed with immunosuppression and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . FLUDARA dosage: TOTAL DAILY DOSE: 30 MG/M2. During the same period patient was treated with AMSACRINE, CYTARABINE, BUSULFAN, CYCLOPHOSPHAMIDE, ANTITHYMOCYTE GLOBULIN, ANTITHYMOCYTE GLOBULIN, IMMUNOSUPPRESSANTS. Patient died.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Fludarabine Side Effects Report #5639538-8
Consumer or non-health professional from FRANCE reported FLUDARABINE problem on Feb 07, 2008. Female patient was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . FLUDARABINE dosage: TOTAL DAILY DOSE: 30 MG/M2. During the same period patient was treated with TREOSULFAN, ANTITHYMOCYTE GLOBULIN. Patient died.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Fludara Side Effects Report #5639565-0
FLUDARA problem was reported by a Consumer or non-health professional from GERMANY on Feb 07, 2008. Female patient was diagnosed with immunosuppression and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . FLUDARA dosage: TOTAL DAILY DOSE: 30 MG/M2. During the same period patient was treated with AMSACRINE, CYTARABINE, BUSULFAN, CYCLOPHOSPHAMIDE, ANTITHYMOCYTE GLOBULIN, ANTITHYMOCYTE GLOBULIN, IMMUNOSUPPRESSANTS. Patient died.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Deferasirox Side Effects Report #5509633-2
Physician from UNITED KINGDOM reported DEFERASIROX problem on Oct 26, 2007. Female patient was treated with DEFERASIROX. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . DEFERASIROX dosage: unknown. Patient recovered.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Rituxan Side Effects Report #5445046-X
RITUXAN problem was reported by a Health Professional from CANADA on Aug 29, 2007. Male patient was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . RITUXAN dosage: 800 MG, UNK. Patient died.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Aldurazyme Side Effects Report #5389806-2
Pharmacist from ITALY reported ALDURAZYME problem on Feb 06, 2007. Female patient was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . ALDURAZYME dosage: unknown. Patient died.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Aldurazyme Side Effects Report #5390193-4
ALDURAZYME problem was reported by a Physician from AUSTRALIA on Jan 02, 2007. Female patient was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . ALDURAZYME dosage: unknown. Patient died on 12/18/2006.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Aldurazyme Side Effects Report #5389806-2
Pharmacist from ITALY reported ALDURAZYME problem on Feb 06, 2007. Female patient was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . ALDURAZYME dosage: unknown. Patient died.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Aldurazyme Side Effects Report #5390193-4
ALDURAZYME problem was reported by a Physician from AUSTRALIA on Jan 02, 2007. Female patient was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: complications of bone marrow transplant, . ALDURAZYME dosage: unknown. Patient died on 12/18/2006.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Prograf Side Effects Report #5613361-2
Physician from JAPAN reported PROGRAF problem on Jan 10, 2008. Male patient, 41 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: angiopathy, complications of bone marrow transplant, graft versus host disease, . PROGRAF dosage: unknown. During the same period patient was treated with METHOTREXATE, METHYLPREDNISOLONE. Patient died.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Velcade Side Effects Report #5572380-5
VELCADE problem was reported by a Physician from SPAIN on Dec 12, 2007. Female patient was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, complications of bone marrow transplant, . VELCADE dosage: 1.30 MG/M2,. Patient died.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Ammonul Side Effects Report #5663683-4
Physician from FRANCE reported AMMONUL problem on Feb 25, 2008. Female patient, 19 years of age, was diagnosed with hyperammonaemia, prophylaxis and was treated with AMMONUL. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, coma, complications of bone marrow transplant, dialysis, epilepsy, haemorrhage, intra-abdominal haematoma, respiratory depression, . AMMONUL dosage: unknown. During the same period patient was treated with POSCONAZOLE, NEXIUM, AMMONAPS, TIENAM, ORGARAN, LEVOCARNIL, ARGININE, MORPHINE. Patient died on 01/24/2008.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Ammonul Side Effects Report #5622930-5
AMMONUL problem was reported by a Physician from FRANCE on Jan 22, 2008. Female patient, 19 years of age, weighting 121.3 lb, was diagnosed with hyperammonaemia, prophylaxis and was treated with AMMONUL. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, coma, complications of bone marrow transplant, epilepsy, gastric disorder, haematoma, haemorrhage, hyperammonaemia, . AMMONUL dosage: unknown. During the same period patient was treated with POSOCONAZOLE, NEXIUM, AMMONAPS, TIENAM, ORGARAN, LEVOCARNIL, ARGININE, MORPHINE. Patient died on 01/24/2008.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Imatinib Side Effects Report #5391966-4
Health Professional from UNITED STATES reported IMATINIB MESYLATE problem on July 13, 2007. Female patient, 42 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, chromosome analysis abnormal, complications of bone marrow transplant, . IMATINIB MESYLATE dosage: 400 MG/D. During the same period patient was treated with IMATINIB MESYLATE. Patient died.
COMPLICATIONS OF BONE MARROW TRANSPLANT : Imatinib Side Effects Report #5391966-4
IMATINIB MESYLATE problem was reported by a Health Professional from UNITED STATES on July 13, 2007. Female patient, 42 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, chromosome analysis abnormal, complications of bone marrow transplant, . IMATINIB MESYLATE dosage: 400 MG/D. During the same period patient was treated with IMATINIB MESYLATE. Patient died.